Indo US Bio-Tech Ltd. (INDOUS) Financial Statements

0 Followers

Indo US Bio-Tech Ltd. Financial Overview

Indo US Bio-Tech Ltd.'s market cap is currently ₹2.03B. The company's EPS TTM is ₹3.559; its P/E ratio is 20.50; Indo US Bio-Tech Ltd. is scheduled to report earnings on January 21, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24
Income Statement
Total Revenue	₹ 1.04B
Gross Profit	₹ 294.70M
Operating Income	₹ 2.11M
EBITDA	₹ 2.23M
Net Income	₹ 162.67M
Balance Sheet
Cash & Short-Term Investments	₹ 2.48M
Total Assets	₹ 978.43M
Total Debt	₹ 148.36M
Net Debt	₹ 145.89M
Total Liabilities	₹ 193.24M
Stockholders' Equity	₹ 785.18M
Cash Flow
Free Cash Flow	₹ -100.69K
Operating Cash Flow	₹ 91.00
Investing Cash Flow	₹ -7.92M
Financing Cash Flow	₹ -14.77M

Currency in INR

Indo US Bio-Tech Ltd. Earnings and Revenue History

Income Statement >

Indo US Bio-Tech Ltd. Debt to Assets

Balance Sheet >

Indo US Bio-Tech Ltd. Cash Flow

Cash Flow >

Indo US Bio-Tech Ltd. Forecast EPS vs Actual EPS

Earnings >